Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias hospitalizationdetailed resultsRodrigues, 2021 (REV) 0.49 [0.02; 15.13] 0.49[0.02; 15.13]Rodrigues, 2021 (REV)10%84NAnot evaluable viral clearance detailed resultsRodrigues, 2021 (REV) 1.00 [0.42; 2.39] 1.00[0.42; 2.39]Rodrigues, 2021 (REV)10%84NAnot evaluable viral clearance by day 7detailed resultsRodrigues, 2021 (REV) 1.00 [0.42; 2.39] 1.00[0.42; 2.39]Rodrigues, 2021 (REV)10%84NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-31 21:36 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons